This report profiles 18 of the largest and fastest growing domestic Chinese pharmaceutical companies by examining their corporate structure, current products, therapeutic areas of focus, R&D efforts, and financial performance. Whether your organization (or department) views domestic Chinese pharmaceutical companies as a competitor, complementor, or as a catalyst, they are becoming an increasing force in the global healthcare industry. While it is not easy to get summarized company-specific information on domestic Chinese pharmaceutical companies, ISR has done the legwork for you. In this report we profile 18 of the largest and fastest growing domestic Chinese pharmaceutical companies. We profile their corporate structure, current products, therapeutic areas of focus, R&D efforts, and financial performance. We think you’ll find this report to be a superior source of information on some of China’s largest and fastest growing pharmaceutical companies. The companies profiled in this report accounted for nearly $15billion USD in revenue in 2010 and over $1.2billion USD in net income. Companies Profiled: 3SBio American Oriental Bioengineering Beijing Double-crane Pharmaceutical Company Beijing Tongrentang China Buchang Pharmaceutical Group China Resources Sanjiu Medical & Pharmaceutical Company Guangzhou Pharmaceutical Holdings Harbin Pharmaceutical Group North China Pharmaceutical Group Qilu Pharmaceutical Company Shandong Xinhua Pharmaceutical Company Shanghai Fosun Pharmaceutical Group Shanghai Pharmaceutical Group Shineway Simcere Pharmaceutical Group Sinovac Biotech Yangtze River Pharmaceutical Group Zhejiang Medicine Company

1. Chinese Domestic Pharma Companies
An in-depth profile of 18 domestic Chinese
pharmaceutical companies
www.ISRreports.com
Industry Standard Research
info@ISRreports.com
Report abstract…
Whether your organization (or department) views domestic Chinese pharmaceutical companies as
a competitor, complementor, or as a catalyst, they are becoming an increasing force in the global
healthcare industry. While it is not easy to get summarized company-specific information on
domestic Chinese pharmaceutical companies, ISR has done the legwork for you. In this report we
profile 18 of the largest and fastest growing domestic Chinese pharmaceutical companies. We
profile their corporate structure, current products, therapeutic areas of focus, R&D efforts, and
financial performance. We think you’ll find this report to be a superior source of information on
some of China’s largest and fastest growing pharmaceutical companies.
The companies profiled in this report accounted for nearly $15billion USD in revenue in 2010 and
over $1.2billion USD in net income.

2. www.ISRreports.com
Industry Standard Research
info@ISRreports.com
Companies profiled
Companies Profiled
1. Harbin Pharmaceutical Group
2. Shineway
3. Beijing Tongrentang
4. Simcere Pharmaceutical Group
5. Qilu Pharmaceutical Company
6. Beijing Double-crane Pharmaceutical Company
7. Shanghai Fosun Pharmaceutical Group
8. Sinovac Biotech
9. 3SBio
10. Shanghai Pharmaceutical Group
11. North China Pharmaceutical Group
12. Yangtze River Pharmaceutical Group
13. China Resources Sanjiu Medical & Pharmaceutical Company
14. Guangzhou Pharmaceutical Holdings
15. China Buchang Pharmaceutical Group
16. Shandong Xinhua Pharmaceutical Company
17. Zhejiang Medicine Company
18. American Oriental Bioengineering
This report contains over 200 pages of information and analysis.
To learn more…
VISIT –
http://www.isrreports.com/report_preview.php?id=20110608

3. Individual and summary information
Summary level
information
example
Individual
company level
information
example
www.ISRreports.com Industry Standard Research info@ISRreports.com